These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 18539966)

  • 1. Cancer stem cells in head and neck squamous cell cancer.
    Prince ME; Ailles LE
    J Clin Oncol; 2008 Jun; 26(17):2871-5. PubMed ID: 18539966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
    Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
    In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stem cell hypothesis in head and neck cancer.
    Graziano A; d'Aquino R; Tirino V; Desiderio V; Rossi A; Pirozzi G
    J Cell Biochem; 2008 Feb; 103(2):408-12. PubMed ID: 17546610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis.
    Yang Z; Schumaker LM; Egorin MJ; Zuhowski EG; Guo Z; Cullen KJ
    Clin Cancer Res; 2006 Oct; 12(19):5817-25. PubMed ID: 17020989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cells in squamous head and neck cancer.
    Albers AE; Chen C; Köberle B; Qian X; Klussmann JP; Wollenberg B; Kaufmann AM
    Crit Rev Oncol Hematol; 2012 Mar; 81(3):224-40. PubMed ID: 21511490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
    Scher RL
    Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cells in head and neck squamous cell carcinoma.
    Shakib K; Schrattenholz A; Soskic V
    Br J Oral Maxillofac Surg; 2011 Oct; 49(7):503-6. PubMed ID: 20832149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H; Fury M; Lee N; Kraus D
    J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells.
    Rossi MJ; Sundararaj K; Koybasi S; Phillips MS; Szulc ZM; Bielawska A; Day TA; Obeid LM; Hannun YA; Ogretmen B
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):55-62. PubMed ID: 15632910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin resistance of the HNSCC cell line UT-SCC-26A can be overcome by stimulation of the EGF-receptor.
    Mandic R; Rodgarkia-Dara CJ; Krohn V; Wiegand S; Grénman R; Werner JA
    Anticancer Res; 2009 Apr; 29(4):1181-7. PubMed ID: 19414362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head and neck cancer: past, present and future.
    Chin D; Boyle GM; Porceddu S; Theile DR; Parsons PG; Coman WB
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1111-8. PubMed ID: 16831082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effects of telomelysin for head and neck squamous cell carcinoma.
    Fujita K; Kimura M; Kondo N; Sakakibara A; Sano D; Ishiguro Y; Tsukuda M
    Oncol Rep; 2008 Dec; 20(6):1363-8. PubMed ID: 19020715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo responsiveness of head and neck squamous cell carcinoma to glufosfamide, a novel alkylating agent.
    Dollner R; Dietz A; Kopun M; Helbig M; Wallner F; Granzow C
    Anticancer Res; 2004; 24(5A):2947-51. PubMed ID: 15517901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
    Winquist RJ; Boucher DM; Wood M; Furey BF
    Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
    Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations.
    Martinez JC; Otley CC; Okuno SH; Foote RL; Kasperbauer JL
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):679-86. PubMed ID: 15061855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a review.
    Silva P; Homer JJ; Slevin NJ; Musgrove BT; Sloan P; Price P; West CM
    Clin Otolaryngol; 2007 Oct; 32(5):337-45. PubMed ID: 17883552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck cancer: meeting summary and research opportunities.
    Grandis JR; Pietenpol JA; Greenberger JS; Pelroy RA; Mohla S
    Cancer Res; 2004 Nov; 64(21):8126-9. PubMed ID: 15520225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells and HNSCC: a potential treatment option? (Review).
    Dunn G; Oliver KM; Loke D; Stafford ND; Greenman J
    Oncol Rep; 2005 Jan; 13(1):3-10. PubMed ID: 15583794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.